Betaxolol is a selective beta-1 adrenergic receptor antagonist widely used to treat glaucoma and hypertension by reducing intraocular pressure and blocking sympathetic nervous system stimulation at cardiac… Read more





![Chemical structure of [[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane-d5](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1185169-90-7-4-2-Cyclopropylmethoxyethylphenoxymethyloxirane-d5.png&w=3840&q=75)






















![Chemical structure of Des[4-(2-cyclopropylmethoxy)] Betaxolol-d5 Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1329488-43-8-Des4-2-cyclopropylmethoxy-Betaxolol-d5-Hydrochloride.png&w=3840&q=75)


Betaxolol is a selective beta-1 adrenergic receptor antagonist widely used to treat glaucoma and hypertension by reducing intraocular pressure and blocking sympathetic nervous system stimulation at cardiac receptors. To ensure the safety and efficacy of this drug substance, laboratories require reliable reference standards for comprehensive analytical testing and method validation. This collection includes high-quality Betaxolol API alongside a range of associated materials, such as pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. These standards are essential for precise impurity profiling and the accurate quantification of drug content during stability studies and quality control processes. By utilizing these characterized reference materials, pharmaceutical researchers can effectively monitor product integrity and maintain compliance with stringent regulatory standards for Betaxolol and its formulations throughout the development lifecycle.